Current management of renal angiomyolipomas (AMLs) include observation, tra
nscatheter embolization and partial or total nephrectomy. Patients symptoms
and size of the lesion are the determinants for the choice of the treatmen
t. In general symptomatic or greater than 8 cm masses require intervention.
A retrospective study of five patients presented with symptomatic lesions
and treated with selective transcatheter embolization, over a 3 year period
was performed in our hospital. A total of eight embolizations were perform
ed, all on an emergency basis due to retroperitoneal bleeding or significan
t hematuria. Surgical intervention was necessary in one case, due to massiv
e rebleeding on the fourth post-procedural day. Two patients rebled within
6 months and 2 years respectively, and were managed successfully with addit
ional embolization. The remaining two patients are still asymptomatic 26 an
d 18 months after the successful initial result. Experience with this proce
dure is reported on with emphasis to the clinical outcome. It is believed t
hat selective arterial embolization should be the standard initial therapy
for symptomatic renal AMLs. (C) 1999 Elsevier Science Ireland Ltd. Ail righ
ts reserved.